W. Dere

2.4k total citations
35 papers, 1.6k citations indexed

About

W. Dere is a scholar working on Molecular Biology, Epidemiology and Orthopedics and Sports Medicine. According to data from OpenAlex, W. Dere has authored 35 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Epidemiology and 7 papers in Orthopedics and Sports Medicine. Recurrent topics in W. Dere's work include Bone health and osteoporosis research (7 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Pneumonia and Respiratory Infections (4 papers). W. Dere is often cited by papers focused on Bone health and osteoporosis research (7 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Pneumonia and Respiratory Infections (4 papers). W. Dere collaborates with scholars based in United States, United Kingdom and France. W. Dere's co-authors include H.U. Bryant, John А. Kanis, Basil Rapoport, Bruce Mitlak, René Rizzoli, Andrew Dawson, Bengt Jönsson, Steven Boonen, Olof Johnell and Anders Odén and has published in prestigious journals such as JAMA, The Journal of Clinical Endocrinology & Metabolism and FEBS Letters.

In The Last Decade

W. Dere

34 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W. Dere United States	17	446	413	311	285	278	35	1.6k
Katerina Trajanoska Netherlands	21	406 0.9×	426 1.0×	373 1.2×	175 0.6×	148 0.5×	46	1.6k
Andromachi Vryonidou Greece	22	124 0.3×	181 0.4×	292 0.9×	339 1.2×	111 0.4×	67	1.9k
G. Berglund Sweden	21	132 0.3×	277 0.7×	267 0.9×	245 0.9×	206 0.7×	31	1.7k
Ernesto Maddaloni Italy	26	191 0.4×	310 0.8×	403 1.3×	616 2.2×	158 0.6×	95	2.1k
Bo Kyung Koo South Korea	30	124 0.3×	771 1.9×	392 1.3×	452 1.6×	115 0.4×	115	2.6k
C. A. Lammersfeld United States	21	107 0.2×	1.5k 3.7×	173 0.6×	392 1.4×	560 2.0×	46	2.4k
Barbara Mason New Zealand	21	1.1k 2.4×	348 0.8×	278 0.9×	289 1.0×	393 1.4×	36	2.4k
Chien‐Liang Chen Taiwan	23	103 0.2×	119 0.3×	230 0.7×	232 0.8×	147 0.5×	83	1.5k
Mahmoud Zirie Qatar	23	85 0.2×	212 0.5×	312 1.0×	180 0.6×	49 0.2×	59	1.5k
Min-Tser Liao Taiwan	19	69 0.2×	191 0.5×	238 0.8×	185 0.6×	75 0.3×	61	1.3k

Countries citing papers authored by W. Dere

Since Specialization

Citations

This map shows the geographic impact of W. Dere's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Dere with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Dere more than expected).

Fields of papers citing papers by W. Dere

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Dere. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Dere. The network helps show where W. Dere may publish in the future.

Co-authorship network of co-authors of W. Dere

This figure shows the co-authorship network connecting the top 25 collaborators of W. Dere. A scholar is included among the top collaborators of W. Dere based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Dere. W. Dere is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Selker, Harry P., Theodora Cohen, Ralph B. D’Agostino, et al.. (2021). A Useful and Sustainable Role for N‐of‐1 Trials in the Healthcare Ecosystem. Clinical Pharmacology & Therapeutics. 112(2). 224–232. 23 indexed citations

Ward, Alistair, Mary Anne Karren, Chase Miller, et al.. (2017). Rapid clinical diagnostic variant investigation of genomic patient sequencing data with iobio web tools. Journal of Clinical and Translational Science. 1(6). 381–386. 4 indexed citations

Byington, Carrie L., Erin Rothwell, Maureen A. Murtaugh, et al.. (2017). Developing sustainable research careers for KL2 scholars: The importance of an inclusive environment and mentorship. Journal of Clinical and Translational Science. 1(4). 226–228. 7 indexed citations

Cooper, Cyrus, Roger A. Fielding, Marjolein Visser, et al.. (2013). Tools in the Assessment of Sarcopenia. Calcified Tissue International. 93(3). 201–210. 184 indexed citations

Cooper, Cyrus, W. Dere, William J. Evans, et al.. (2012). Frailty and sarcopenia: definitions and outcome parameters. Osteoporosis International. 23(7). 1839–1848. 239 indexed citations

Kaufman, JM, J.-Y. Reginster, Steven Boonen, et al.. (2012). Treatment of osteoporosis in men. Bone. 53(1). 134–144. 67 indexed citations

Goldhahn, Jörg, Jean-Marc Féron, John А. Kanis, et al.. (2012). Implications for Fracture Healing of Current and New Osteoporosis Treatments: An ESCEO Consensus Paper. Calcified Tissue International. 90(5). 343–353. 92 indexed citations

Rizzoli, René, Jonathan D. Adachi, Cyrus Cooper, et al.. (2012). Management of Glucocorticoid-Induced Osteoporosis. Calcified Tissue International. 91(4). 225–243. 72 indexed citations

Miossec, Pierre, C L Verweij, Lars Klareskog, et al.. (2011). Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies. Annals of the Rheumatic Diseases. 70(10). 1713–1718. 26 indexed citations

10.

Bruyère, Olivier, John А. Kanis, Maria Luisa Brandi, et al.. (2010). The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES). Osteoporosis International. 21(5). 713–722. 7 indexed citations

11.

Abadie, Éric, J. D. Ringe, D Ethgen, et al.. (2005). Recommendations for the Registration of Agents to be Used in the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis: Updated Recommendations from the Group for the Respect of Ethics and Excellence in Science. Seminars in Arthritis and Rheumatism. 35(1). 1–4. 17 indexed citations

12.

Hockett, Richard D., Sandra C. Kirkwood, Bruce Mitlak, & W. Dere. (2002). Pharmacogenomics in Endocrinology. The Journal of Clinical Endocrinology & Metabolism. 87(6). 2495–2499. 3 indexed citations

13.

Kanis, John А., Olof Johnell, Anders Odén, et al.. (2000). Risk of Hip Fracture Derived from Relative Risks: An Analysis Applied to the Population of Sweden. Osteoporosis International. 11(2). 120–127. 105 indexed citations

14.

Odén, Anders, Andrew Dawson, W. Dere, et al.. (1998). Lifetime Risk of Hip Fractures is Underestimated. Osteoporosis International. 8(6). 599–603. 143 indexed citations

15.

Casali, L Gobio, et al.. (1992). Cefaclor advanced formulation versus cefaclor in the treatment of pneumonia.. PubMed. 14(4). 570–7. 3 indexed citations

16.

Dere, W.. (1992). Acute bronchitis: Results of U.S. and European trials of antibiotic therapy. The American Journal of Medicine. 92(6). S53–S57. 12 indexed citations

17.

Dere, W., et al.. (1992). Efficacy of cefaclor AF in the treatment of skin and skin-structure infections.. PubMed. 14(3). 470–9. 7 indexed citations

18.

Derriennic, M., et al.. (1992). Cefaclor AF in the treatment of streptococcal pharyngitis/tonsillitis.. PubMed. 68 Suppl 3. S43–6; discussion S46. 3 indexed citations

19.

Dere, W., Hideshi Hirayu, & Basil Rapoport. (1986). Thyrotropin and cyclic AMP regulation of ras proto‐oncogene expression in cultured thyroid cells. FEBS Letters. 196(2). 305–308. 22 indexed citations

20.

Dere, W., Hideshi Hirayu, & Basil Rapoport. (1985). TSH AND CAMP ENHANCE EXPRESSION OF THE MYC PROTO-UNCOGENE IN CULTURED THYROID CELLS. Endocrinology. 117(5). 2249–2251. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact